Lata Mathew

FDA investigator · also recorded as Cre Lata C. Mathew, Faye Lata C. Mathew

Appears on 24 documents from 2017 to 2024, most often at sites in India. Most often cites general requirements (21 CFR 211.160).

24
Documents on file
5.0
Observations per 483
2017
First seen
2024
Most recent

What they cite most

From 119 observations

Activity by year

2017: 4, 2018: 3, 2019: 5, 2020: 4, 2021: 2, 2022: 4, 2023: 1, 2024: 1

Where

India 11 · New Jersey 8 · New York 3 · California 1 · Japan 1

Often inspects with

Unnee Ranjan· Stacie Woods· Ko U. Min

Is Lata Mathew coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

24 documents, newest first
FirmOpen
483 Nosch Labs Pvt. Ltd.Sep 13, 2024 · Hyderabad, India
483 Aucta Pharmaceuticals, Inc.Jun 7, 2023 · Piscataway, New Jersey
483 Aurobindo Pharma Limited Unit lXNov 18, 2022 · Hatnoora Mandal Sangareddy, India
483 MSN Life Sciences Private LimitedJun 3, 2022 · Bhiknoor (Village), India
483 Wyeth Pharmaceutical Division of Wyeth Holdings LLCApr 13, 2022 · Pearl River, New York
483 Aspire Pharmaceuticals Inc.Feb 3, 2022 · Somerset, New Jersey
483 STIRA PHARMACEUTICALS LLCNov 5, 2021 · Fairfield, New Jersey

About this profile

What does Lata Mathew inspect?

Lata Mathew appears on 24 documents on file covering 22 sites, most often in India.

What do they cite most often?

21 CFR 211.160 (general requirements), followed by 21 CFR 211.192 and 21 CFR 211.100.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Lata Mathew is dated Sep 13, 2024.